OSLI Retina

April 2020 Supplement

Issue link: http://osliretina.healio.com/i/1240026

Contents of this Issue


Page 2 of 55

April 2020 · Vol. 51, No. 4 S3 6900 Grove Road Thorofare, NJ 08086-9447 Phone: 856-848-1000 Email: osli@healio.com Healio.com/OSLIRetina SLACK I N C O R P O R A T E D ® Follow OSLIJournal OSLI Retina SLACK Incorporated SLACK Incorporated Chief Content Officer Joan-Marie Stiglich, ELS EDITORIAL Senior Editorial Director David W. Mullin Executive Editor Cara Dickinson SALES Chief Commercial Officer Matthew J. Holland Group Sales Director, Eye Care Scott Wright National Account Manager Laura Renna Director, Sales Administration and Support Carolyn Boerner Recruitment/Classified Sales Representative Bernadette Hamilton Sales Coordinator, Recruitment Jennifer Carroll Reprints/Eprints Licensing Opportunities: The Sheridan Press 800-635-7181 ext. 8065 DESIGN Creative Director Thomas Cavallaro Production and Circulation Director Cheryl McKeown Production Associate Ryan Davis The Wyanoke Group President Peter N. Slack Chief Operating Officer John C. Carter Chief Financial Officer Darrell Blood Senior Vice President Denise Mealey Chief Technology Officer Linda Baker Award-Winning Presentations From the 2019 Retina World Congress The Retina World Congress (RWC) is a focused learning initiative that unites retina specialists from around the globe to spearhead innovation in retinal therapy to fos- ter ongoing dialogue about treating retinal disease, learn about emerging technologies and treatments, and to share best practices and the latest clinical trial data. These ob- jectives are accomplished through both a collaborative Congress meeting occurring every 2 years (which began in 2017) and a peer-reviewed scientific and clinical pe- riodical. RWC seeks to provide the essential platform to facilitate the exchange of knowledge and best practices in retina on a global scale and includes practicing retina specialists, retina fellows, and residents. The goals of RWC are: To provide open access to retinal continuing medi- cal education; to improve patient care by providing a forum for education on the latest retina knowledge from experts around the world; to support a global scientific and clinical exchange on current retinal data and practice; to high- light innovation in retinal therapies and diagnostics; and to engage delegates from Retina Societies from around the world. GAP ANALYSIS Currently, there is no medical education conference that focuses entirely on retina practice from a global perspective. By uniting societies from around the globe, this conference provides a worldwide perspective focused on reti- nal medical education. As the burden of retinal diseases, including age-related macular degenera- tion and diabetic macular edema, continues to increase, there has also been tremendous advancement in the treatment and management of these diseases. Continual innovation in the diagnosis, treatment, and monitoring of retinal diseases has contributed significantly to an increased need for continued edu- cation and the exchange of knowledge between members of the global retina community. The papers presented in this supplement highlight some of the progress being made in the treatment and management of these diseases. Rishi P. Singh, MD Cole Eye Institute Cleveland Clinic Foundation Associate Editor, OSLI Retina doi: 10.3928/23258160-20200402-01

Articles in this issue

Links on this page

Archives of this issue

view archives of OSLI Retina - April 2020 Supplement